ARMProgram.com Trend Top Navigation






Escherichia coli (SOUTHCENTRAL Data)
  2004 2005 2006 2007 2008 2009 2010
amoxicillin/clavulanate 91.9%
n=234
      
ampicillin 55%
n=1867
51%
n=261
     
ampicillin/sulbactam 61.4%
n=1867
52.1%
n=261
     
cefazolin 91.5%
n=1867
92%
n=261
     
cefotetan 100%
n=275
      
cefuroxime 92%
n=1201
      
cefotaxime 99%
n=509
      
ceftazidime 97.9%
n=1201
96.9%
n=261
     
ceftriaxone 97.6%
n=1589
98.1%
n=261
     
cefepime 99.8%
n=1867
98.1%
n=261
     
ciprofloxacin 84.4%
n=1867
75.9%
n=261
     
levofloxacin 84.7%
n=1867
75.9%
n=261
     
gatifloxacin 80.6%
n=320
      
TMP/SMX 76.5%
n=814
73.2%
n=261
     
nitrofurantoin 97.9%
n=234
      
tetracycline 73.9%
n=234
      
gentamicin 93%
n=1867
82%
n=261
     
tobramycin 94.3%
n=1867
85.8%
n=261
     
amikacin 99.1%
n=234
      
aztreonam 97%
n=234
      
imipenem 100%
n=1867
100%
n=261
     
piperacillin 65%
n=1287
      
pip/taz 97.1%
n=1867
98.1%
n=261
     
ticarcillin/clavulanate 87.9%
n=621
      
Totals86.9%
n=27657
83%
n=3393
         

This data is accurate as of: 11/22/2016 11:54:07 AM

Drugs with less than 10 isolates are removed from the chart and from the graph. The following drugs had some data removed: .



Site Menu: Home Page | About ARM | Trends | Contact Us

University of Florida ARMProgram.com is a project run by the University of Florida.
Copyright 2011. All Rights Reserved.
Site by JMarc Technologies, LLC